Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2OEG6
|
|||
| Drug Name |
CIN-109
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66] | Phase 1 | [1] | |
| Company |
CinFina Pharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Growth/differentiation factor 15 (GDF15) | Target Info | Replacement | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of CinFina Pharma | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.